Blinded by the light: molecular imaging in pancreatic adenocarcinoma
- PMID: 21106729
- DOI: 10.1158/1078-0432.CCR-10-2825
Blinded by the light: molecular imaging in pancreatic adenocarcinoma
Abstract
The early detection and optimal perisurgical management of pancreatic adenocarcinoma are paramount goals in our quest to increase cure rates in this lethal malignancy. Molecular imaging techniques may be the conduit through which new genomic and proteomic discoveries about this disease are brought to the clinic.
©2010 AACR.
Comment on
-
Plectin-1 as a novel biomarker for pancreatic cancer.Clin Cancer Res. 2011 Jan 15;17(2):302-9. doi: 10.1158/1078-0432.CCR-10-0999. Epub 2010 Nov 23. Clin Cancer Res. 2011. PMID: 21098698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
